Sort   by:  
 Page size 
UnknownProduction of bio-xylitol from D-xylose by an engineered Pichia pastoris expressing a recombinant xylose reductase did not require any auxiliary substrate as electron donor.
Not available
S-EPMC7898734 | biostudies-literature
UnknownIntegration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism.
Not available
S-EPMC10447532 | biostudies-literature
UnknownPeripheral serum metabolomic profiles inform central cognitive impairment.
Not available
S-EPMC7441317 | biostudies-literature
UnknownMetabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.
Not available
S-EPMC6609722 | biostudies-literature
UnknownSerum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex-Dependent Manner.
Not available
S-EPMC10916590 | biostudies-literature
UnknownBile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts.
Not available
S-EPMC6797798 | biostudies-literature
UnknownAltered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
Not available
S-EPMC6454538 | biostudies-literature
UnknownMetabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease.
Not available
S-EPMC7691449 | biostudies-literature
UnknownAlterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression.
Not available
S-EPMC7925685 | biostudies-literature
UnknownMulti-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease.
Not available
S-EPMC9547905 | biostudies-literature
Sort   by:  
 Page size